Status:
COMPLETED
12- Week Open Label Treatment of Refractory Bipolar Depression
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborating Sponsors:
Bristol-Myers Squibb
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
1. Determine the change in symptomatology and function in refractory bipolar depression, when treated with combination of DEP+AZP for a period of 12 weeks 2. Determine the tolerability and safety of A...
Detailed Description
)Determine the change in symptomatology and function in refractory bipolar depression, when treated with combination of DEP+AZP for a period of 12 weeks 2\) Determine the tolerability and safety of A...
Eligibility Criteria
Inclusion
- diagnosis of bipolar disorder I or II according to M.I.N.I.
- patient has signed informed consent
- male, or female who is using effective birth control if of child bearing age
- age 18 and above
- currently in a depressed phase, with or without psychotic features, of the illness based on DSM-IV/MINI criteria
- score of more than 19 on the MADRS
- history of treatment refractory bipolar depression as defined by failure of the depressive episode to respond to a mood stabilizer alone or a combination of 2 or more mood stabilizers or a combination of a mood stabilizer and an antidepressant
Exclusion
- current liver disease,
- illness precluding the use of depakote er
- patients who have been treated with a DEP and AZP combination in the past
- Alcohol/drug dependence in the past one month
- CNS neoplasms, demyelinating diseases, degenerative neurological condition or active CNS infection
- history of seizure, known EEG with frank paroxysmal activity, known CT of brain showing gross structural abnormalities, cerebral vascular disease by history or structural brain damage from trauma
- thyroid dysfunction
- unstable general medical condition
- require antipsychotic other than abilify
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00223496
Start Date
September 1 2004
End Date
September 1 2009
Last Update
May 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univ of Texas Helath Science Center at San Antonio
San Antonio, Texas, United States, 78229